Come up with a name for your new list and we'll add to it:
ViThera Pharmaceuticals raised a round of funding on April 17, 2012. Investors include
Johnson & Johnson.
ViThera Pharmaceuticals is a biotech company harnessing the synthetic potential of bacteria to produce therapeutic molecules within the body to develop a new treatment for Inflammatory Bowel Disease. …